[Moderate @entity1007 in XXXX . An index of familial pathology?].

@entity1 @entity407 @entity1007 @entity14822 @entity412 @entity74 @entity4977 @entity731 @entity65 @entity165
Out of 44 @entity1 (with 200 mg/dl @entity165 ) 22, with constantly high levels of @entity165 were studied. All belong to a @entity1 population from Madrid which 95 percentile for @entity165 was 204 mg/dl. Fifty nine subjects, first degree relatives of these 22 @entity1 (17 families) plus probands were studied to determine if moderately elevated @entity165 levels during infancy are related to any form of @entity74 . Serum lipidic levels, anthropometric measurements, dietary habits a history of @entity65 ( @entity65 ), were evaluated in all these 81 individuals. @entity1007 was encountered in 13 of the 59 non probands and high @entity412 levels in 6 @entity1 . More than one member of the family was to have some form of @entity4977 in 12 of 17 families (71%) and in 10 the metabolic abnormality was of a type associated with a higher risk to suffer @entity65 . Five families had a combined @entity407 of the multiple lipoproteinemic (4 familiar heterozygotic @entity1007 and one @entity407 with a double phenotype II B and V). All family members were apparently healthy and had no knowledge of their underlying @entity14822 . In this group of families antecedents of morbi-mortality because of @entity731 were more frequent that in group control families. Authors conclude that a moderately elevated serum @entity165 level during infancy may be a marker for @entity4977 . Detection in infantile population of serum @entity165 levels 200 mg/dl should prompt us to perform a more complete lipidic evaluation both in @entity1 as well as in their families.
